King, E. A., Davis, J. W., & Degner, J. F. (2019). Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS genetics, 15(12), e1008489. https://doi.org/10.1371/journal.pgen.1008489
Chicago-Zitierstil (17. Ausg.)King, Emily A., J. Wade Davis, und Jacob F. Degner. "Are Drug Targets with Genetic Support Twice as Likely to Be Approved? Revised Estimates of the Impact of Genetic Support for Drug Mechanisms on the Probability of Drug Approval." PLoS Genetics 15, no. 12 (2019): e1008489. https://doi.org/10.1371/journal.pgen.1008489.
MLA-Zitierstil (9. Ausg.)King, Emily A., et al. "Are Drug Targets with Genetic Support Twice as Likely to Be Approved? Revised Estimates of the Impact of Genetic Support for Drug Mechanisms on the Probability of Drug Approval." PLoS Genetics, vol. 15, no. 12, 2019, p. e1008489, https://doi.org/10.1371/journal.pgen.1008489.